FIRST MANHATTAN CO. LLC. - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 66 filers reported holding VIKING THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$3,000
-25.0%
1,4000.0%0.00%
Q2 2022$4,000
+33.3%
1,400
+40.0%
0.00%
Q1 2022$3,000
-25.0%
1,0000.0%0.00%
Q4 2021$4,000
-33.3%
1,0000.0%0.00%
Q3 2021$6,000
+20.0%
1,0000.0%0.00%
Q2 2021$5,000
-99.9%
1,000
-99.5%
0.00%
-100.0%
Q3 2018$3,516,000
-30.7%
201,853
-62.3%
0.02%
-34.5%
Q2 2018$5,074,000
+177.4%
534,753
+27.7%
0.03%
+190.0%
Q1 2018$1,829,000418,7530.01%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 250,000$2,005,0005.90%
Sio Capital Management, LLC 731,453$5,866,0001.40%
KNOTT DAVID M 218,102$1,749,0000.71%
ArrowMark Colorado Holdings LLC 8,813,578$70,685,0000.63%
DAFNA Capital Management LLC 209,200$1,678,0000.58%
Park West Asset Management LLC 1,545,075$12,391,0000.52%
SPHERA FUNDS MANAGEMENT LTD. 590,000$4,732,0000.39%
Cornerstone Capital, Inc. 245,796$1,971,0000.28%
Ikarian Capital, LLC 150,000$1,203,0000.20%
Ikarian Capital, LLC 150,000$1,203,0000.20%
View complete list of VIKING THERAPEUTICS INC shareholders